The Patent Finder

Canariabio Inc.

Also on record
Records under this name other than the patents Canariabio Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to Canariabio Inc.

PatentTitleStatus Expires Confidence
US 7,147,850Therapeutic Binding Agents Against MUC-1 Antigen and Methods for Their Use
Term ended
Ended no later than Oct 13, 2021 · Low confidence
Term endedEnded no later than Oct 13, 2021Low confidence
US 6,689,355Therapeutic Method and Composition Utilizing Antigen-Antibody Complexation and Presentation by Dendritic Cells
Term ended
Term ended May 11, 2021 · High confidence
Term endedTerm ended May 11, 2021High confidence
US 8,038,994Combination therapy for treating disease
Term ended
Term ended Apr 2, 2021 · From the USPTO record
Term endedTerm ended Apr 2, 2021From the USPTO record
US 6,716,966Therapeutic binding agents against MUC-1 antigen and methods for their use
Term ended
Term ended Aug 18, 2020 · From the USPTO record
Term endedTerm ended Aug 18, 2020From the USPTO record
US 6,241,985Method and composition for reconforming multi-epitopic antigens to initiate an immune response
Term ended
Term ended Mar 20, 2018 · From the USPTO record
Term endedTerm ended Mar 20, 2018From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited